Tesamorelin CAS #: 218949-48-5

Tesamorelin(2mg/Vial 10vial/Kit ) CAS #: 218949-48-5 Molecular Formula:C211H366N72O67S1 Molecular Weight:5135.89 Appearance:white powder Purity (HPLC):≥98.00% Tesamorelin is a synthetic peptide consisting of all 44 amino acids of hGRF with the addition of a trans-3-Hexenoic acid group. Tesamorelin (also known as Egrifta) is a synthetic form of -releasing hormone which is used in the treatment of HIV-associated lipodystrophy. Tesamorelin, (formerly known as TH9507), is a type of peptide called a -releasing factor (GHRF). GHRF causes to be created and spread in the body, which helps increase metabolism, reduce belly fat, improve body shape, and use of energy. Tesamorelin (formerly known as TH9507) is a synthetic -releasing factor that stimulates the pituitary gland in the brain to secrete ; this indirect approach appears to maintain more stable, natural levels, like CJC-1295 DAC,. Clinical trials have shown that tesamorelin significantly reduces abdominal fat with fewer side effects than human itself, although abdominal fat may return after the Tesamorlein is discontinued (depending upon the individual). Tesamorelin has been shown to reduce lipodystrophy in HIV-infected individuals as well as similarly reducing abdominal fat in NON-HIV-Infected individuals.